SCHEMBL4856281

SCHEMBL4856281

COc1ccc(OC)c(C(=O)/C=C/c2ccccc2OCCN(C)C)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
LMNA P02545 1/20 0.60
GAA P10253 1/20 0.60
ATM Q13315 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
ABCG2 Q9UNQ0 2/20 0.56
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
PDE4D Q08499 2/20 0.53
MAOB P27338 1/20 0.52
ALDH1A1 P00352 2/20 0.51
NR1H4 Q96RI1 1/20 0.51
KDM4E B2RXH2 1/20 0.51
KEAP1 Q14145 1/20 0.51
NFE2L2 Q16236 1/20 0.51
TNFRSF1A P19438 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856367 1.00 MAPT (0.60) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4851307 0.95 MAPT (0.59) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4851327 0.95 MAPT (0.59) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4856370 0.88 PDE4A (0.62) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4849956 0.87 LMNA (0.53) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4855122 0.85 AR (0.48) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4856553 0.85 AR (0.48) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4845554 0.84 ABCG2 (0.73) MAPTABCG2PDE4APDE4BPDE4C
SCHEMBL4851201 0.84 ABCG2 (0.73) MAPTABCG2PDE4APDE4BPDE4C
SCHEMBL3695218 0.84 MAPT (0.59) MAPTSMN1; SMN2LMNAGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed